Browse > Article
http://dx.doi.org/10.13104/imri.2022.26.1.48

Multifocal Extranodal Involvement in Diffuse Large B-cell Lymphoma (DLBCL): Bone, Soft tissue, Testis, and Kidney  

Cho, Jae Sung (Department of Radiology, Jeju National University Hospital)
Lee, Kyung Ryeol (Department of Radiology, Jeju National University Hospital)
Kim, Bong Soo (Department of Radiology, Jeju National University Hospital)
Choi, Guk Myung (Department of Radiology, Jeju National University Hospital)
Lee, Jeong Sub (Department of Radiology, Jeju National University Hospital)
Huh, Jung Sik (Department of Urology, Jeju National University Hospital)
Jang, Bogun (Department of Pathology, Jeju National University Hospital)
Publication Information
Investigative Magnetic Resonance Imaging / v.26, no.1, 2022 , pp. 48-54 More about this Journal
Abstract
In this report we present a case of disseminated diffuse large B-cell lymphoma (DLBCL) in a 79-year-old man affecting the bone, soft tissue, testis, and both kidneys, which are rarely affected sites. The formation of a large mass in the bone, soft tissue, and testis due to DLBCL is rarely seen nowadays. In this article, we describe the imaging findings and clinical significance of multifocal extranodal involvement in DLBCL, focusing on involvement of bone, soft tissue, and testis.
Keywords
Non-Hodgkin lymphoma; Diffuse large B-cell lymphoma; Extranodal; Bone; Soft tissue, Testis;
Citations & Related Records
Times Cited By KSCI : 1  (Citation Analysis)
연도 인용수 순위
1 Gundrum JD, Mathiason MA, Moore DB, Go RS. Primary testicular diffuse large B-cell lymphoma: a population-based study on the incidence, natural history, and survival comparison with primary nodal counterpart before and after the introduction of rituximab. J Clin Oncol 2009;27:5227-5232   DOI
2 Takahashi H, Tomita N, Yokoyama M, et al. Prognostic impact of extranodal involvement in diffuse large B-cell lymphoma in the rituximab era. Cancer 2012;118:4166-4172   DOI
3 Cheson BD, Fisher RI, Barrington SF, et al. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 2014;32:3059-3068   DOI
4 Zhou Z, Sehn LH, Rademaker AW, et al. An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab era. Blood 2014;123:837-842   DOI
5 Chun CW, Jee WH, Park HJ, et al. MRI features of skeletal muscle lymphoma. AJR Am J Roentgenol 2010;195:1355-1360   DOI
6 Lim CY, Ong KO. Imaging of musculoskeletal lymphoma. Cancer Imaging 2013;13:448-457   DOI
7 Zicherman JM, Weissman D, Gribbin C, Epstein R. Best cases from the AFIP: primary diffuse large B-cell lymphoma of the epididymis and testis. Radiographics 2005;25:243-248   DOI
8 Wang D, Huo Y, Chen S, et al. Whole-body MRI versus (18)F-FDG PET/CT for pretherapeutic assessment and staging of lymphoma: a meta-analysis. Onco Targets Ther 2018;11:3597-3608   DOI
9 Kim SH. Collison tumor of adenocarcinoma and diffuse large B-cell lymphoma in the rectum: a case report and literature review. Investig Magn Reson Imaging 2019;23:374-380   DOI
10 Mayerhoefer ME, Karanikas G, Kletter K, et al. Evaluation of diffusion-weighted MRI for pretherapeutic assessment and staging of lymphoma: results of a prospective study in 140 patients. Clin Cancer Res 2014;20:2984-2993   DOI